<DOC>
	<DOCNO>NCT01501929</DOCNO>
	<brief_summary>The purpose study determine Nebivolol improve microvascular perfusion skeletal muscle exercise hypertensive patient whether improvement accompany reduction vascular oxidative stress increase endothelial nitric oxide synthase ( eNOS ) expression human .</brief_summary>
	<brief_title>Effects Nebivolol Skeletal Muscle During Exercise Hypertensive Patients</brief_title>
	<detailed_description>In 32 untreated stage 1 hypertensive subject , investigator measure blood pressure ; noninvasive cardiac output thoracic electrical bioimpedance ( Bioz , Cardio Dynamics ) ; forearm mediate vasodilation ( FMD ) , non-invasive assessment endothelial function ; collect venous endothelial cell ; measure microvascular perfusion use Octafluoropropane microbubble contrast agent ( Definity ) . To obtain FMD , brachial artery image use ultrasound . After clear picture obtain , cuff arm inflate tight five minute . During follow , subject 's arm continue image monitor maximal increase brachial artery diameter . To collect endothelial cell , thin wire insert vein collect cell inner line vein . The cell collect process stained several protein involve endothelial cell function , use immunofluorescent technique . To assess microvascular perfusion skeletal muscle , contrast agent ( Definity ) administer baseline 5 minute rhythmic hand grip exercise 30 % maximal voluntary contraction . The investigator randomize subject receive 12 week Metoprolol Nebivolol , use cross design . There 4 week washout period two treatment . During washout period , subject follow 2 week drug withdrawal . Subjects found BP &gt; 140/90 mmHg , start hydrochlorothiazide ( HCTZ ) 25 mg daily . Then subject ask return 2 week . At time HCTZ stop start earlier visit , subject switch remain treatment ( Nebivolol Metoprolol ) . Then , investigator assess microvascular perfusion skeletal muscle rest handgrip exercise , endothelial function ( FMD ) , change endothelial cell protein expression 12 week Nebivolol 12 week Metoprolol treatment subject .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<criteria>Men woman stage I primary untreated hypertension ( BP 140159/9099 mmHg ) Age 1865 Congestive heart failure Coronary artery disease Left ventricular hypertrophy echocardiography ECG History stroke Average blood pressure &gt; 159/99 mmHg Bradycardia rest heart rate &lt; 55 bpm Chronic kidney disease serum creatinine &gt; 1.4 mg/dL Asthma chronic obstructive pulmonary disease Women pregnant planning become pregnant Hypersensitivity beta blocker , hydrochlorothiazide , Definity Any history substance abuse ( tobacco ) Concomitant drug treatment raise endogenous nitric oxide level , include nitrate phosphodiesterase V inhibitor ( Viagra , Levitra ) History symptomatic bradycardia heart block Patients Righttoleft , bidirectional , transient righttoleft cardiac shunt Hypersensitivity perflutren , blood , blood product albumin .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>hypertension</keyword>
	<keyword>blood pressure</keyword>
	<keyword>blood pressure medication</keyword>
	<keyword>metoprolol</keyword>
	<keyword>nebivolol</keyword>
	<keyword>vascular oxidative stress</keyword>
	<keyword>nitric oxide</keyword>
	<keyword>nitric oxide synthase ( eNOS )</keyword>
	<keyword>endothelium</keyword>
	<keyword>endothelial dysfunction</keyword>
	<keyword>endothelial cell protein expression</keyword>
	<keyword>microvascular blood flow</keyword>
	<keyword>flow mediate dilation</keyword>
	<keyword>handgrip exercise</keyword>
	<keyword>endothelial cell collection</keyword>
	<keyword>microbubbles</keyword>
	<keyword>Definity</keyword>
</DOC>